organophosphonates has been researched along with Insulin Sensitivity in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ecelbarger, CM; Kumari, M; Mishra, P; Pandey, G; Sharma, R; Tiwari, S | 1 |
Arnett, DK; Bagchi, S; Chi, BH; Heimburger, DC; Kabagambe, EK; Kiage, JN; Koethe, JR; Nyirenda, CK; Wellons, MF | 1 |
Jackson, AG; Moyle, GJ; Randell, PA; Yale, K; Zhong, L | 1 |
Back, DJ; Boffito, M; Jackson, AG; Mandalia, S; Moyle, GJ; Randell, PA; Taylor, J; Tjia, JF | 1 |
Liu, G | 1 |
Carr, A; Chuah, J; Cooper, DA; Doong, N; French, M; Hoy, J; Hudson, J; Law, M; Mallal, S; Smith, D | 1 |
1 review(s) available for organophosphonates and Insulin Sensitivity
Article | Year |
---|---|
Protein tyrosine phosphatase 1B inhibition: opportunities and challenges.
Topics: Acetates; Animals; Benzoates; Enzyme Inhibitors; Humans; Hydroquinones; Insulin Resistance; Molecular Mimicry; Oligonucleotides, Antisense; Organophosphonates; Phosphotyrosine; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Salicylates; Structure-Activity Relationship | 2003 |
3 trial(s) available for organophosphonates and Insulin Sensitivity
Article | Year |
---|---|
The effect of tenofovir disoproxil fumarate on whole-body insulin sensitivity, lipids and adipokines in healthy volunteers.
Topics: Adenine; Adipokines; Adult; Anti-HIV Agents; Cholesterol; Cholesterol, LDL; Cross-Over Studies; Drug Administration Schedule; Glucose Clamp Technique; HIV Seronegativity; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Young Adult | 2010 |
Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men.
Topics: Adenine; Adipose Tissue; Adult; Anti-HIV Agents; Blood Glucose; Carbamates; Confidence Intervals; Drug Administration Schedule; Drug Combinations; Dyslipidemias; Furans; HIV Infections; HIV-1; Humans; Insulin; Insulin Resistance; Lamivudine; Lipids; Lopinavir; Male; Organophosphates; Organophosphonates; Pyrimidinones; Ritonavir; Sulfonamides; Tenofovir | 2010 |
HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Carnitine; Dideoxynucleosides; Drug Administration Schedule; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hydroxyurea; Insulin Resistance; Lipodystrophy; Male; Middle Aged; Nevirapine; Organophosphonates; Quality of Life; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome | 2001 |
2 other study(ies) available for organophosphonates and Insulin Sensitivity
Article | Year |
---|---|
Deletion of insulin receptor in the proximal tubule and fasting augment albumin excretion.
Topics: Albuminuria; Animals; Creatinine; Epithelial Cells; Fasting; Fluorescein-5-isothiocyanate; Gene Expression Regulation; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Kidney Tubules, Proximal; Low Density Lipoprotein Receptor-Related Protein-2; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalenes; Organophosphonates; Primary Cell Culture; Receptor, Insulin; Receptors, Cell Surface; Serum Albumin | 2019 |
Cardiometabolic risk factors among HIV patients on antiretroviral therapy.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cyclopropanes; Female; HIV; HIV Infections; Humans; Insulin Resistance; Lamivudine; Male; Middle Aged; Nevirapine; Organophosphonates; Risk Factors; Stavudine; Tenofovir; Triglycerides; Zambia; Zidovudine | 2013 |